Home/News/The Future of Gene Editing with Jennifer Doudna
Bloomberg Markets3 min read

The Future of Gene Editing with Jennifer Doudna

Jennifer Doudna, a Nobel Prize-winning scientist and Professor at the University of California, Berkeley, discussed the origins of CRISPR gene editing technology and its future implications in an interview with Emily Chang for Bloomberg. Doudna highlighted that the initial discovery of CRISPR was not driven by commercial interests but by fundamental scientific curiosity about microbial defense mechanisms. She explained that the technology's potential extends far beyond what is often portrayed in popular media, particularly in Silicon Valley, which she believes sometimes misunderstands the complexities and ethical considerations of biological research. Doudna emphasized the importance of rigorous scientific validation and responsible innovation in the field of gene editing. She also touched upon other significant breakthroughs in the broader field of gene editing, underscoring the rapid pace of advancement and the transformative power of these tools. The conversation aimed to provide a more nuanced understanding of gene editing, moving beyond hype to focus on scientific reality and societal impact.

Original source — read the full reporting at the publisher:

Read on Bloomberg Markets